Mednext Biotech Limited — Ofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Ofloxacin · $1.3M export value · DGFT Verified
Mednext Biotech Limited is the #11 Indian exporter of Ofloxacin with $1.3M in export value and 26 verified shipments. Mednext Biotech Limited holds a 0.4% market share in Ofloxacin exports across 4 countries. The company exports 3 pharmaceutical products worth $2.6M across 3 therapeutic categories.
Mednext Biotech Limited — Ofloxacin Export Profile: Buyers & Destinations
Where Does Mednext Biotech Limited Export Ofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SIERRA LEONA | $140.8K | 7 | 53.7% |
| NIGER | $100.0K | 2 | 38.1% |
| LIBERIA | $13.8K | 9 | 5.3% |
| SIERRA LEONE | $7.2K | 5 | 2.8% |
| CAMEROON | $480 | 6 | 0.2% |
Mednext Biotech Limited exports Ofloxacin to 5 countries. The largest destination is SIERRA LEONA accounting for 53.7% of Mednext Biotech Limited's Ofloxacin shipments, followed by NIGER (38.1%) and LIBERIA (5.3%). These destinations reflect Mednext Biotech Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ofloxacin from Mednext Biotech Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OKAR AGENCY | SIERRA LEONA | $140.7K | 6 |
| OFFICE NATIONAL DES PRODUITS | NIGER | $100.0K | 2 |
| DEEPA PHARMACY | LIBERIA | $13.0K | 1 |
| EXCEL BIOLIFE SL LIMITED | SIERRA LEONE | $3.1K | 2 |
| EXCEL BIOLIFE SL LTD | SIERRA LEONE | $3.1K | 2 |
| CC S ENTERPRISE | SIERRA LEONE | $999 | 1 |
| KARISH EYE CARE | LIBERIA | $667 | 5 |
| CRISTALLIN PLUS SARL | CAMEROON | $480 | 6 |
| M/S C.C.& S ENTERPRIS | SIERRA LEONA | $98 | 1 |
| SILOAM EYE CENTER | LIBERIA | $76 | 3 |
Mednext Biotech Limited supplies Ofloxacin to 10 buyers globally. The largest buyer is OKAR AGENCY (SIERRA LEONA), followed by OFFICE NATIONAL DES PRODUITS (NIGER) and DEEPA PHARMACY (LIBERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ofloxacin Export Value and How Much Does Mednext Biotech Limited Contribute?
India exported $71.8M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. Mednext Biotech Limited contributes $1.3M to this total, accounting for 0.4% of India's Ofloxacin exports. Mednext Biotech Limited ships Ofloxacin to 5 countries through 10 buyers.
What Is the Average Shipment Value for Mednext Biotech Limited's Ofloxacin Exports?
Mednext Biotech Limited's average Ofloxacin shipment value is $50.0K per consignment, based on 26 shipments totaling $1.3M. The largest destination is SIERRA LEONA (53.7% of Mednext Biotech Limited's Ofloxacin exports).
How Does Mednext Biotech Limited Compare to Other Indian Ofloxacin Exporters?
Mednext Biotech Limited ranks #11 among 1094 Indian Ofloxacin exporters with a 0.4% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($12.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.1M), MICRO LABS LIMITED ($8.4M). Mednext Biotech Limited processed 26 shipments to 4 destination countries.
What Ofloxacin Formulations Does Mednext Biotech Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN 2MG/ML SOLUTION FOR INFUSI | $129.9K | 3 |
| MEDICIP - 500 TABLET CIPROFLOXACIN TAB 5 | $100.0K | 2 |
| CIPRODEEP TABLET (CIPROFLOXACIN TABLET 500MG) | $13.0K | 1 |
| PHARMACEUTICAL ITEM- Medicip (Ciprofloxacin HCI 500mg film-coated tablet) (TAX INV.EXPORT/23-24/151 DT.14.02.2024) | $9.3K | 1 |
| MEDICINES-CIPROEX 10MLCiprofloxacin Ophthalmic SolutionEye Drops USP 0.3 % w/v 10m TAX DOCUMENT EXPORT/23-24/104 DT.11.0 | $3.3K | 2 |
| MEDICINES-CIPROEX-D 10ML E/E DROPS Ciprofloxacin & Dexamethasone Eye/Ear Drops0.3% w/v + 0.1% w/v 10ml TAX DOCUMENT EXP | $3.0K | 2 |
| Ciprofloxacin 2 mg/ml solution for infus | $1.3K | 1 |
| PHARMACEUTICAL ITEM-Ciprofloxacin Solut | $999 | 1 |
| PHARMACEUTICAL ITEM-CIPROFLOXACIN 0.30% | $480 | 6 |
| PHARMACEUTICAL PRODUCT-OFLOXACIN Zuflo | $410 | 2 |
Mednext Biotech Limited exports 18 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN 2MG/ML SOLUTION FOR INFUSI with 3 shipments worth $129.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Mednext Biotech Limited Compare to Nearest Ofloxacin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | MEDCELL PHARMA | $1.9M | 38 | 4 | $50.0K |
| 2 | DR REDDYS LABORATORIES LIMITED | $1.3M | 26 | 1 | $50.0K |
| 11 | MEDNEXT BIOTECH LIMITED ★ | $1.3M | 26 | 4 | $50.0K |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LTD | $1.1M | 22 | 8 | $50.0K |
| 14 | ZYPHER LIFESCIENCES PRIVATE LIMITED | $150.0K | 3 | 1 | $50.0K |
Mednext Biotech Limited ranks #11 among 1094 Indian Ofloxacin exporters. Average shipment value of $50.0K compared to the market average of $65.6K. The closest competitors by value are MEDCELL PHARMA and DR REDDYS LABORATORIES LIMITED.
Which Indian Ports Ship Ofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,841 | 12.3% |
| DELHI AIR CARGO ACC (INDEL4) | 1,504 | 10.0% |
| SAHAR AIR | 1,292 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR | 894 | 6.0% |
| Bombay Air | 655 | 4.4% |
| JNPT/ NHAVA SHEVA SEA | 645 | 4.3% |
| Delhi Air | 361 | 2.4% |
About Mednext Biotech Limited
Mednext Biotech Limited exports 3 products worth $2.6M. Beyond Ofloxacin, top products include Ciprofloxacin, Collagen. View the complete Mednext Biotech Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Mednext Biotech Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 29 individual customs records matching Mednext Biotech Limited exporting Ofloxacin, covering 18 formulations to 5 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ofloxacin Export Data from Mednext Biotech Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Mednext Biotech Limited's Ofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Mednext Biotech Limited
Full Company Profile →
3 products · $2.6M total trade · 3 categories
Ofloxacin Stats
Company Overview
Top Products by Mednext Biotech Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Mednext Biotech Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current shipment-level data, contact TransData Nexus.